Seeking Alpha

12120341

12120341
Send Message
View as an RSS Feed
View 12120341's Comments BY TICKER:
Latest  |  Highest rated
  • Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator [View article]
    I think (hope) we are seeing the bottom in the share price. It is all up from here.
    Sep 16 07:59 PM | 1 Like Like |Link to Comment
  • MannKind: Moving From Short To Long? [View article]
    They are quiet for competitive reasons.
    Aug 26 03:14 PM | 1 Like Like |Link to Comment
  • MannKind Is Ripe: Let's Do Big Things, But Fundamentals First [View article]
    No way this takes one to one and a half years to get to double digits. This sounds like an argument from a shortie.
    Aug 26 11:39 AM | 1 Like Like |Link to Comment
  • MannKind Corporation: Back To The Fundamentals [View article]
    It was filed. Just not the details.

    http://bit.ly/1oicR9A
    Aug 22 06:05 PM | Likes Like |Link to Comment
  • MannKind Corporation: Back To The Fundamentals [View article]
    Hi, George, and thanks for the article. While no one can predict the future, I suspect that 5 years down the road mnkd will be outright sold. The proceeds from such a sale would be used to further fund Al Manns trust. Mann doesn't seem to hold on to companies once they start becoming profitable.
    Aug 20 01:41 PM | 1 Like Like |Link to Comment
  • Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership [View article]
    I don't have a facebook account and I just gave you a thumbs up, so you must be doing something wrong. Try signing in to yahoo mail account.
    Aug 19 02:58 AM | Likes Like |Link to Comment
  • Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership [View article]
    How soon do you believe it will be before we see these surprise sales volumes?
    Aug 13 10:27 PM | Likes Like |Link to Comment
  • MannKind: Looking Beyond The Short-Term Disappointment [View article]
    Hi George,

    Thanks for another well thought out article. I am curious to hear your thoughts on new applications for technosphere. It is my understanding that it will take 3-5 years of testing to get approval for new drugs such as inhaled migraine medicine. If so, if mnkd is outright sold within the next 5 years it would be sold without any new inhaled drugs on the market. Am I way off base?
    Aug 12 11:18 PM | Likes Like |Link to Comment
  • Will MannKind Partner Or Go It Alone? [View article]
    Now that is funny! The sad apart is I agree.
    Aug 11 09:52 AM | 2 Likes Like |Link to Comment
  • MannKind set for opening gap up [View news story]
    I hope he is unable to cover. Ha ha ha.
    Aug 11 08:03 AM | 2 Likes Like |Link to Comment
  • Sanofi, MannKind reach licensing agreement for Afrezza insulin [View news story]
    They are paying almost 1B for the RIGHTS to sell afrezza. Mnkd profits from manufacturing afrezza and gets 35% royalties plus mnkd has technosphere which is where the real money is. It is an excellent agreement.
    Aug 11 06:19 AM | 10 Likes Like |Link to Comment
  • Afrezza Is A Brilliant Technology Without A Compelling Marketing Story [View article]
    Very compelling.
    Aug 11 06:15 AM | 2 Likes Like |Link to Comment
  • Sanofi, MannKind reach licensing agreement for Afrezza insulin [View news story]
    To the moon, mnkd!
    Aug 11 04:25 AM | 3 Likes Like |Link to Comment
  • Will MannKind Partner Or Go It Alone? [View article]
    Up almost 30% already overseas!
    Aug 11 03:34 AM | 4 Likes Like |Link to Comment
  • Will MannKind Partner Or Go It Alone? [View article]
    Just announced - sanofi is the global partner. 150m up front with additional 775m for meeting targets. So almost 1 billion dollars for a drug that is cheap to make. Shortie is going to fry! WOOT WOOT!
    Aug 11 01:57 AM | 4 Likes Like |Link to Comment
COMMENTS STATS
88 Comments
191 Likes